New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Whether you’ve searched the internet far and wide for the best ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

The FDA is seeking feedback on whether — and how — to expand the number of men prescribed testosterone treatment.

Impulsive, anxious, overheated, scatter-brained, depressed and in pain are just some of the terms that many women use to describe themselves when they reach perimenopause, or the years that ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

The Trump administration Thursday proposed two rules targeting hospitals that treat transgender children and youth using Medicare and Medicaid as the lever. The move would affect trans youth who have ...